Sign in
  1. Home
  2. Companies
  3. Stock Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. PHIO

$ 1.05 1.46%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITAL

Shares

 5.98 M

Market Cap[1]

 $ 6.28 M

EBITDA (LTM)

 $ -9.22 M

P/E (LTM)

 -0.744828

P/S (LTM)

 -

EPS (LTM)

 -1.45

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Aclaris Therapeutics Aclaris Therapeutics
ACRS
 		$ 5.65 6.11 % $ 692 M Nasdaq Global Select Market usaUSA
Фармсинтез Фармсинтез
LIFE
 		- - - MOEX russiaRussia
AbbVie AbbVie
ABBV
 		$ 261.61 1.7 % $ 463 B NYSE,SPB usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
 		$ 11.07 1.61 % $ 3.31 B Nasdaq Global Select Market canadaCanada
Agenus Agenus
AGEN
 		$ 7.08 2.07 % $ 211 M Nasdaq Capital Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Amryt Pharma plc Amryt Pharma plc
AMYT
 		- - $ 621 M Nasdaq Global Select Market britainBritain
Evelo Biosciences Evelo Biosciences
EVLO
 		- -14.46 % $ 27.9 M Nasdaq Global Select Market usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
 		- -14.27 % $ 1.7 M Nasdaq Global Market singaporeSingapore
Acorda Therapeutics Acorda Therapeutics
ACOR
 		- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
 		- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
 		$ 5.38 0.28 % $ 285 M Nasdaq Capital Market usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
 		$ 33.41 0.16 % $ 1.94 B Nasdaq Global Select Market,SPB usaUSA
Adagene Adagene
ADAG
 		$ 3.3 2.94 % $ 195 M Nasdaq Global Market chinaChina
iTeos Therapeutics iTeos Therapeutics
ITOS
 		- - $ 411 M Nasdaq Global Market usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
 		$ 4.63 21.05 % $ 20 M Nasdaq Capital Market israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
 		$ 24.7 2.05 % $ 3.75 B Nasdaq Global Select Market,SPB usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
 		$ 0.07 9.81 % $ 855 K Nasdaq Global Select Market,SPB usaUSA
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
 		$ 23.52 458.67 % $ 98.9 M Nasdaq Global Select Market usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		- - $ 2.17 B Nasdaq Global Market usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
 		$ 5.13 0.1 % $ 983 M Nasdaq Global Select Market canadaCanada
ADC Therapeutics SA ADC Therapeutics SA
ADCT
 		$ 1.09 2.35 % $ 139 M NYSE schweizSchweiz
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		- -11.43 % $ 502 K NYSE American usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
 		- 17.91 % $ 11.1 M Nasdaq Capital Market usaUSA
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
 		$ 5.03 2.65 % $ 3.36 M Nasdaq Capital Market usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		$ 27.54 0.04 % $ 4.64 B Nasdaq Global Select Market,SPB usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
 		$ 0.22 1.52 % $ 356 K NYSE American usaUSA
ADMA Biologics ADMA Biologics
ADMA
 		$ 9.18 0.16 % $ 2.19 B Nasdaq Global Market usaUSA
Axcella Health Axcella Health
AXLA
 		- -16.42 % $ 249 M Nasdaq Global Market usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
 		- 57.95 % $ 12.8 M NYSE usaUSA
Atreca Atreca
BCEL
 		- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Berkeley Lights Berkeley Lights
BLI
 		- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Achieve Life Sciences Achieve Life Sciences
ACHV
 		$ 7.15 1.27 % $ 312 M Nasdaq Capital Market usaUSA
Baudax Bio Baudax Bio
BXRX
 		- 0.59 % $ 63 K Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
 		- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		- - $ 3.45 B Nasdaq Global Select Market usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
 		- -55.98 % $ 2.15 M Nasdaq Global Market usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		- - $ 789 M Nasdaq Capital Market usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
 		- - $ 7.29 B Nasdaq Capital Market usaUSA
AC Immune SA AC Immune SA
ACIU
 		$ 2.67 2.6 % $ 269 M Nasdaq Global Market schweizSchweiz
Akebia Therapeutics Akebia Therapeutics
AKBA
 		$ 1.0 5.6 % $ 257 M Nasdaq Global Market usaUSA
Alector Alector
ALEC
 		$ 2.17 1.64 % $ 224 M Nasdaq Global Select Market,SPB usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
 		$ 5.05 0.96 % $ 49.9 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.